Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness.

Autor: Yates, Abi G.1,2 (AUTHOR), Weglinski, Caroline M.1 (AUTHOR), Ying, Yuxin1 (AUTHOR), Dunstan, Isobel K.1 (AUTHOR), Strekalova, Tatyana3,4 (AUTHOR), Anthony, Daniel C.1,3,5 (AUTHOR) daniel.anthony@pharm.ox.ac.uk
Zdroj: Journal of Neuroinflammation. 1/6/2022, Vol. 19 Issue 1, p1-16. 16p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje